Dr Martens /DOCS

-2.03%
-
1D1W1MYTD1YMAX

About Dr Martens

Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Ticker

DOCS

Sector

Consumer Cyclicals

Trading on

LSE

Industry

Footwear

CEO

Kenny Wilson

Employees

2,591

Headquarters

London, United Kingdom

Dr Martens Metrics

BasicAdvanced
£904.17M
Market cap
9.12
P/E ratio
£0.10
EPS
-
Beta
£0.06
Dividend rate
6.21%
Dividend yield
£904.17M
£1.75
£0.72
1.52M
£0.06
2.44
0.879
125.605
145.682
56.4%
21.291
4.88%
10.27%
29.07%
12.99%
9.117
0.925
2.556
9.217
6.21%
6.21%
2.14%
-41.64%
14.17%
19.84%

What the Analysts think about Dr Martens

Analyst Ratings

Majority rating from 9 analysts.
Hold

Price Targets

Average projection from 9 analysts.
1.06% upside
High £1.10
Low £0.85
£0.94
Current price
£0.95
Average price target

Dr Martens Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.8% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
£395.8M
-31.96%
Net income
£19M
-77.43%
Profit margin
4.8%
-66.83%

Dr Martens Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 39.19%
QuarterlyAnnual
Q1 22
Q3 23
Q1 23
Q3 24
Q1 24
Actual
£0.13
£0.05
£0.08
£0.02
-
Expected
£0.10
£0.05
£0.10
£0.01
£0.07
Surprise
27.76%
-4.05%
-14.02%
39.19%
-
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Dr Martens stock?

Dr Martens (DOCS) has a market cap of £904.17M as of April 14, 2024.

What is the P/E ratio for Dr Martens stock?

The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 9.12 as of April 14, 2024.

Does Dr Martens stock pay dividends?

Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of April 14, 2024, the dividend rate is £0.0584 and the yield is 6.21%. Dr Martens has a payout ratio of 56.4% on a trailing twelve-month basis.

When is the next Dr Martens dividend payment date?

The next Dr Martens (DOCS) dividend payment date is unconfirmed.

What is the beta indicator for Dr Martens ?

Dr Martens (DOCS) does not currently have a Beta indicator.

What is the Dr Martens stock price target?

The target price for Dr Martens (DOCS) stock is £0.95, which is 1.06% above the current price of £0.94. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Dr Martens  stock

Buy or sell Dr Martens stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing